Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F

Biochemical Journal

Volumn 467, Issue 3, 2015, Pages 517-527

  Datta, Geeta ^a,b   Kramer, Philip A ^c   Johnson, Michelle S ^c   Sawada, Hirotaka ^c   Smythies, Lesley E ^a   Crossman, David K ^d   Chacko, Balu ^b,c   Ballinger, Scott W ^b,c   Westbrook, David G ^c   Mayakonda, Palgunachari ^a   Anantharamaiah, G M ^a,d   Darley Usmar, Victor M ^b,c   White, C Roger ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

ApoA I mimetic peptide; Fatty acid oxidation; Macrophage polarization; Mitochondrial respiration; Oxygen consumption rate; PPAR

Indexed keywords

2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; ADENOSINE TRIPHOSPHATE; APOLIPOPROTEIN A I MIMETIC PEPTIDE 4F; APOLIPOPROTEIN A1; CD163 ANTIGEN; CD36 ANTIGEN; ETOMOXIR; FATTY ACID BINDING PROTEIN 4; LIPOPROTEIN; LIVER X RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN A-I MIMETIC PEPTIDE 4F; BENZAMIDE DERIVATIVE; BIOMIMETIC MATERIAL; FATTY ACID; PEPTIDE; PYRIDINE DERIVATIVE;

AEROBIC METABOLISM; ARTICLE; BIOENERGY; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; LIPID METABOLISM; MACROPHAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NUCLEAR REPROGRAMMING; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; TRANSCRIPTION REGULATION; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MITOCHONDRION; MONOCYTE; PHYSIOLOGY;

ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEIN A-I; BENZAMIDES; BIOMIMETIC MATERIALS; CELL DIFFERENTIATION; CELLS, CULTURED; ENERGY METABOLISM; FATTY ACIDS; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; MACROPHAGES; MITOCHONDRIA; MONOCYTES; OXYGEN CONSUMPTION; PEPTIDES; PPAR GAMMA; PYRIDINES;

EID: 84934962045     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20131635     Document Type: Article

References (51)

1. Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Wagner, R. A., Greaves, D. R., Murray, P. J. and Chawla, A. (2006) Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab. 4, 13-24
2. Rodriguez-Prados, J. C., Traves, P. G., Cuenca, J., Rico, D., Aragones, J., Martin-Sanz, P., Cascante, M. and Boscá, L. (2010) Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 185, 605-614
3. Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A. W. and Chawla, A. (2007) Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447, 1116-1120
4. Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W. and Chawla, A. (2008) Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab. 7, 496-507
5. Bensinger, S. J. and Tontonoz, P. (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454, 470-477
6. Im, S. S. and Osborne, T. F. (2011) Liver X receptors in atherosclerosis and inflammation. Circ. Res. 108, 996-1001
7. Alleva, D. G., Johnson, E. B., Lio, F. M., Boehme, S. A., Conlon, P. J. and Crowe, P. D. (2002) Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-γ: counter-regulatory activity by IFN-γ. J. Leukoc. Biol. 71, 677-685 PubMed
8. Rigamonti, E., Chinetti-Gbaguidi, G. and Staels, B. (2008) Regulation of macrophage functions by PPAR-α, PPAR-γ, and LXRs in mice and men. Arterioscler. Thromb. Vasc. Biol. 28, 1050-1059
9. Zhang, Y., Repa, J. J., Gauthier, K. and Mangelsdorf, D. J. (2001) Regulation of lipoprotein lipase by the oxysterol receptors, LXRα and LXRβ. J. Biol. Chem. 276, 43018-43024
10. Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P. and Evans, R. M. (2001) PPAR-γ dependent and independent effects on macrophage gene expression in lipid metabolism and inflammation. Nat. Med. 7, 48-52
11. Bouhlel, M. A., Derudas, B., Rigamonti, E., Dievart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N. et al. (2007) PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137-143
12. Hock, M. B. and Kralli, A. (2009) Transcriptional control of mitochondrial biogenesis and function. Annu. Rev. Physiol. 71, 177-203
13. Tavakoli, S., Zamora, D., Ullevig, S. and Asmis, R. (2013) Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis. J. Nucl. Med. 54, 1661-1667
14. Navab, M., Anantharamaiah, G. M., Reddy, S. T., Van Lenten, B. J., Hough, G., Wagner, A., Nakamura, K., Garber, D. W., Datta, G., Segrest, J. P. et al. (2004) Human apolipoprotein AI and A-I mimetic peptides: potential for atherosclerosis reversal. Curr. Opin. Lipidol. 15, 645-649
15. White, C. R., Anantharamaiah, G. M. and Datta, G. (2010) HDL mimetic peptides: novel therapeutic strategies for the treatment of inflammatory vascular disease. In The HDL Handbook: Biological Functions and Clinical Implications (Komoda, T., ed.), pp. 179-197, Elsevier, Amsterdam
16. Smythies, L. E., White, C. R., Maheshwari, A., Palgunachari, M. N., Anantharamaiah, G. M., Chaddha, M., Kurundkar, A. R. and Datta, G. (2010) Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. Am. J. Physiol. Cell Physiol. 298, C1538-C1548
17. White, C. R., Smythies, L. E., Crossman, D. K., Palgunachari, M., Anantharamaiah, G. M. and Datta, G. (2012) Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F. Arterioscler. Thromb. Vasc. Biol. 32, 2631-2639
18. Datta, G., Chaddha, M., Hama, S., Navab, M., Fogelman, A. M., Garber, D. W., Mishra, V. K., Epand, R. M., Epand, R. F., Lund-Katz, S. et al. (2001) Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J. Lipid Res. 42, 1096-1104 PubMed
19. Smythies, L. E., Maheshwari, A., Clements, R., Eckhoff, D., Novak, L., Vu, H. L., Mosteller-Barnum, L. M., Sellers, M. and Smith, P. D. (2006) Mucosal IL-8 and TGF-β recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. J. Leukoc. Biol. 80, 492-499
20. Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O. R. et al. (2010) SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation. Nature 464, 121-125
21. Hill, B. G., Dranka, B. P., Zou, L., Chatham, J. C. and Darley-Usmar, V. M. (2009) Importance of the bioenergetics reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. Biochem. J. 424, 99-107
22. Dranka, B. P., Benavides, G. A., Diers, A. R., Giordano, S., Zelickson, B. R., Reily, C., Zou, L., Chatham, J. C., Hill, B. G., Zhang, J. et al. (2011) Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radical Biol. Med. 51, 1621-1635
23. Ballinger, S. W., Van Houten, B., Conklin, C. A., Jin, G. F. and Godley, B. F. (1999) Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp. Eye Res. 68, 765-772
24. Smathers, R. L. and Petersen, D. R. (2011) The human fatty acid-binding protein family: evolutionary divergences and functions. Hum. Genomics 5, 170-191
25. Lee, K., Kerner, J. and Hoppel, C. L. (2011) Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J. Biol. Chem. 286, 25655-25662
26. Lemasters, J. J. and Holmuhamedov, E. (2006) Voltage-dependent anion channel (VDAC) as mitochondrial governator: thinking outside the box. Biochim. Biophys. Acta 1762, 181-190
27. Amo, T., Sato, S., Saiki, S., Wolf, A. M., Toyomizu, M., Gautier, C. A., Shen, J., Ohta, S. and Hattori, N. (2011) Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects. Neurobiol. Dis. 41, 111-118
28. Mosser, D. M. and Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969
29. White, C. R., Garber, D. W. and Anantharamaiah, G. M. (2014) Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review. J. Lipid Res. 55, 2007-2021
30. De Nardo, D., Labzin, L. I., Kono, H., Seki, R., Schmidt, S. V., Beyer, M., Xu, D., Zimmer, S., Lahrmann, C., Schildberg, F. A. et al. (2014) High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat. Immunol. 15, 152-160
31. Lawrence, T. and Natoli, G. (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750-761
32. Gaus, K., Rodriguez, M., Ruberu, K. R., Gelissen, I., Sloane, T. M., Kritharides, L. and Jessup, W. (2005) Domain-specific lipid distribution in macrophage plasma membranes. J. Lipid Res. 46, 1526-1538
33. Hong, C. and Tontonoz, P. (2008) Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr. Opin. Genet. Dev. 18, 461-467
34. Ayers, S. D., Nedrow, K. L., Gillilan, R. E. and Noy, N. (2007) Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARγ by FABP4. Biochemistry 46, 6744-6752
35. Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P. and Evans, R. M. (2001) PPAR-γ dependent and independent effects on macrophage gene expression in lipid metabolism and inflammation. Nat. Med. 7, 48-52
36. Lushchak, O. V., Piroddi, M., Galli, F. and Lushchak, V. I. (2014) Aconitase post-translational modification as a key in linkage between Krebs cycle, iron homeostasis, redox signaling, and metabolism of reactive oxygen species. Redox Rep. 19, 8-15
37. Newsholme, P., Gordon, S. and Newsholme, E. A. (1987) Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem. J. 242, 631-636 PubMed
38. Brand, M. D. and Nicholls, D. G. (2011) Assessing mitochondrial dysfunction in cells. Biochem. J. 435, 297-312
39. Thorpe, C. and Kim, J. J. (1995) Structure and mechanism of action of the acyl-CoA dehydrogenases. FASEB J. 9, 718-725 PubMed
40. Osumi, T., Hashimoto, T. and Ui, N. (1980) Purification and properties of acyl-CoA oxidase from rat liver. J. Biochem. 87, 1735-1746 PubMed
41. Porcheray, F., Viaud, S., Rimaniol, A. C., Léone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D. and Gras, G. (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481-489 PubMed
42. Wu, J. S., Lin, T. N. and Wu, K. K. (2009) Rosiglitazone and PPAR-γ overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins. J. Cell. Physiol. 220, 58-71
43. Lelliott, C. J., Medina-Gomez, G., Petrovic, N., Kis, A., Feldmann, H. M., Bjursell, M., Parker, N., Curtis, K., Campbell, M., Hu, P. et al. (2006) Ablation of PGC-1β results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol. 4, e369
44. Azevedo, L. C. (2010) Mitochondrial dysfunction during sepsis. Endocr. Metab. Immune Disord. Drug Targets 10, 214-223
45. Moon, K. H., Hood, B. L., Mukhopadhyay, P., Rajesh, M., Abdelmegeed, M. A., Kwon, Y. I., Conrads, T. P., Veenstra, T. D., Song, B. J. and Pacher, P. (2008) Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 135, 1344-1357
46. Chopra, M., Golden, H. B., Mullapudi, S., Dowhan, W., Dostal, D. E. and Sharma, A. C. (2011) Modulation of myocardial mitochondrial mechanisms during severe polymicrobial sepsis in the rat. PLoS ONE 6, e21285
47. Brealey, D. and Singer, M. (2003) Mitochondrial dysfunction in sepsis. Curr. Infect. Dis. Rep. 5, 365-371
48. Fink, M. P. (2001) Cytopathic hypoxia: mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit. Care Clin. 17, 219-237
49. Navab, M., Anantharamaiah, G. M., Hama, S., Hough, G., Reddy, S. T., Frank, J. S., Garber, D. W., Handattu, S. and Fogelman, A. M. (2005) D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 25, 1426-1432
50. Garber, D. W., Datta, G., Chaddha, M., Palgunachari, M. N., Hama, S. Y., Navab, M., Fogelman, A. M., Segrest, J. P. and Anantharamaiah, G. M. (2001) A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J. Lipid Res. 42, 545-552 PubMed
51. Fajas, L., Schoonjans, K., Gelman, L., Kim, J. B., Najib, J., Martin, G., Fruchart, J. C., Briggs, M., Spiegelman, B. M. and Auwerx, J. (1999) Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol. Cell. Biol. 19, 5495-5503 PubMed